Fact CheckerSign in

NCT06107153CompletedPhase 3

Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

Source: ClinicalTrials.gov · Last updated 30 Mar 2025

Brief summary (registry, in English)

In this study, we aim to explore the beneficial effect of early short-term (two weeks), self-titrated, basal-only insulin therapy on the degree of glycemic control over 1-year follow through a prospective cohort.

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
243 (actual)
First submitted
24 Oct 2023
Start date
Nov 2023
Primary completion date
Nov 2024
Lead sponsor
University of Basrah
NCT number
NCT06107153

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 243
  • From Nov 2023 to the primary completion date, Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current or recent steroid use.

Other illness

  • Patients with type 1 diabetes mellitus,
  • History of coronary heart disease and heart failure.

Lab values

  • GFR less than 60 mL/min/1.73 m2.

Other

  • Urine ketone dipstick + and above at baseline or anytime throughout the study.
  • Pregnancy.

Who the study is looking for

  • Newly diagnosed type 2 diabetes mellitus on no glucose-lowering drugs and
  • Either hemoglobin A1c equal to or more than 9% and/or random blood glucose equal to or more than 300 mg/dl.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faiha Specialized Diabetes, Endocrine, and Metabolism Center
Coordinator of this site? Confirm its status
BasraIraqUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.